Drug Trial Radar · NCT05011513
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
Last checked: Nov 20, 2026Latest source record: Aug 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,440
Actual
Start
Aug 25, 2021
Primary completion
Jul 25, 2022
Study completion Jul 25, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 18, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary hypothesis to be tested is whether or not there is a difference in time to sustained alleviation of all targeted COVID-19 signs and symptoms through Day 28 between PF-07321332/ritonavir and placebo.
Conditions
- COVID-19
Interventions
PF-07321332Drug
PF-07321332 (tablet)
RitonavirDrug
Ritonavir (capsule)
PlaceboDrug
Placebo (tablet)
PlaceboDrug
Placebo (capsule)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Sustained Alleviation of Overall COVID-19 Signs and Symptoms Through Day 28Time frame: From Day 1 to Day 28
Locations
225 sites in 20 countries. Site status is shown where the registry gives one.
Cahaba Research Inc
Pelham, Alabama
The Institute for Liver Health dba Arizona Clinical Trials
Mesa, Arizona
Matrix Mobile Health Clinic #49, #35, and #62
Scottsdale, Arizona
The Institute for Liver Health dba Arizona Clinical Trials
Tucson, Arizona
Hope Clinical Research
Canoga Park, California
Lightship
El Segundo, California
Ascada Research
Fullerton, California
Atella Clinical Research LLC.
La Palma, California
Ark Clinical Research
Long Beach, California
South Bay Clinical Research Institute
Redondo Beach, California
Benchmark Research
Sacramento, California
Optimus Medical Group
San Francisco, California
Hope Clinical Research (COVID Satellite Site)
West Hills, California
Future Innovative Treatments, LLC
Colorado Springs, Colorado
Synergy Healthcare
Bradenton, Florida
MOORE Clinical Research, Inc.
Brandon, Florida
TrueBlue Clinical Research
Brandon, Florida
Herco Medical and Research Center Inc
Coral Gables, Florida
Advance Clinical Research Group
Cutler Bay, Florida
Beautiful Minds Clinical Research Center
Cutler Bay, Florida
Omega Research Orlando, LLC
DeBary, Florida
Eastern Research Inc
Hialeah, Florida
Inpatient Research Clinic
Hialeah, Florida
Doral Medical Research, LLC
Hialeah, Florida
Unlimited Medical Research Group, LLC
Hialeah Gardens, Florida
ASCLEPES Research Centers
Lutz, Florida
Angels Clinical Research Institute
Miami, Florida
LCC Medical Research Institute, LLC
Miami, Florida
Premium Medical Research Corp
Miami, Florida
Global Health Clinical Trials Corp
Miami, Florida
South Florida Research Center, Inc.
Miami, Florida
I.V.A.M. Clinical & Investigational Center, LLC
Miami, Florida
C'A Research
Miami, Florida
ProLive Medical Research, Corp.
Miami, Florida
Entrust Clinical Research
Miami, Florida
Reed Medical Research
Miami, Florida
Kendall South Medical Center, Inc.
Miami, Florida
Clinical Site Partners, Inc d/b/a CSP Miami
Miami, Florida
Coral Research Clinic Corp
Miami, Florida
Pro-Care Research Center, Corp.
Miami Gardens, Florida
Showing 40 of 225 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.